[1] GONZÁLEZ CA,AGUDO A.Carcinogenesis,prevention and early detection of gastric cancer:where we are and where we should go[J].Intern J Cancer,2012,130(4):745.
[2] 何峰,张小霞.奥沙利铂联合卡培他滨对胃癌病人的疗效及对免疫功能的影响[J].蚌埠医学院学报,2013,38(9):1096.
[3] 陈灏珠,林果为.实用内科学[M].北京:人民卫生出版社,2009:1989.
[4] 王文鹏,薛英威,禚春杨,等.不同部位进展期胃癌病理临床病理特征分析及预后分析[J].中华胃肠外科杂志,2015,18(12):1248.
[5] 孙明星,宫喜明.进展期胃癌浸润浆膜层或邻近器官相关因素分析[J].辽宁医学院学报,2012,33(1):33.
[6] LOYD RA,MCCLELLAN DA.Update on the evaluation and management of functional dyspepsia[J].Am Fam Physician,2011,83(5):547.
[7] 张玉坤.Mir-1271及RTEF-1在青年及老年胃癌中的表达及意义[J].中国老年学杂志,2013,29(15):1973.
[8] CAMARGO MC,GOTO Y,ZABALETA J,et al.Sex hormones,hormonal interventions,and gastric[J].Cancer Epidemiol Biomarkers Prevent,2012,21(1):20.
[9] 郭永强,田大宇.不同年龄组胃癌病人的临床病理特征和预后分析[J].临床消化病杂志,2012,24(1):20.
[10] 王显松,陈德琴.预警症状与胃癌预后的相关性研究[J].浙江医学,2012,34(7):509.
[11] 李兆申.胃肠道疾病内镜诊断与治疗学[M].北京:人民卫生出版社,2009:239.
[12] GUO T,LU XA,YANG AM,et al.Enhanced magnifying endoscopy for differential diagnosis of superficial gastric lesions identified with white-light endoscopy[J].Gastric Cancer,2014,17(1):122.
[13] GRAZIOSI L,MARINO E,CAVAZZONI E,et al.Prognostic value of the seventh AJCC/UICC TNM classification of non-cardia gastric cancer.[J].Wold J Surg Oncol,2013,11:103.